Back to the basis: Breast cancer heterogeneity from an etiological perspective

Journal of the National Cancer Institute

Volumn 106, Issue 8, 2014, Pages

  Weigelt, Britta ^a   Reis Filho, Jorge S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR;

AGE; AGE DISTRIBUTION; BASAL LIKE BREAST CANCER; BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; COLLOID CARCINOMA; DATA BASE; DISEASE ASSOCIATION; GERMLINE MUTATION; HUMAN; INCIDENCE; MEDULLARY CARCINOMA; MULTIPLE PREGNANCY; ONSET AGE; PARITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR;

EID: 84930727432     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju211     Document Type: Review

References (15)

1. Weigelt B, Reis-Filho JS. Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol. 2009;6(12):718-730.
2. Reis-Filho JS, Pusztai L. Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet. 2011;378(9805):1812-1823.
3. Parker JS, Mullins M, Cheang MC, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009;27(8):1160-1167.
4. Curtis C, Shah SP, Chin SF, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346-352.
5. Weigelt B, Pusztai L, Ashworth A, et al. Challenges translating breast cancer gene signatures into the clinic. Nat Rev Clin Oncol. 2012;9(1):58-64.
6. Anderson WF, Rosenberg PS, Prat A, et al. How many etiological subtypes of breast cancer: two, three, four or more? J Natl Cancer Inst. In press.
7. Weigelt B, Horlings HM, Kreike B, et al. Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol. 2008;216(2):141-150.
8. Anderson TJ, Sufi F, Ellis IO, et al. Implications of pathologist concordance for breast cancer assessments in mammography screening from age 40 years. Hum Pathol. 2002;33(3):365-371.
9. Lakhani SR, O. EI, Schnitt SJ, et al. WHO Classification of Breast Tumors. Lyon: IARC; 2012.
10. Polyak K, Vogt PK. Progress in breast cancer research. Proc Natl Acad Sci U S A. 2012;109(8):2715-2717.
11. Melchor L, Molyneux G, Mackay A, et al. Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models. J Pathol. 2014;233(2):124-137.
12. Molyneux G, Geyer FC, Magnay FA, et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell. 2010;7(3):403-417.
13. Lim E, Vaillant F, Wu D, et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med. 2009;15(8):907-913.
14. Blanpain C. Tracing the cellular origin of cancer. Nat Cell Biol. 2013;15(2):126-134.
15. Chaffer CL, Weinberg RA. Cancer cell of origin: spotlight on luminal progenitors. Cell Stem Cell. 2010;7(3):271-272.